Streetbeat News

Regulatory

HD

Home Depot's stock is sliding due to concerns that Trump's victory could derail a potential housing recovery.

Portfolio Pulse from

November 06, 2024 | 7:00 pm

AXP

HBAN

SYF

Financial stocks, including American Express, Synchrony Financial, and Huntington Bancshares, surged due to the prospect of financial deregulation.

Portfolio Pulse from

November 06, 2024 | 7:00 pm

LYFT

UBER

Uber and Lyft drivers in Massachusetts have won the right to unionize through a state ballot measure. This is a first in the U.S., but there are concerns it might prevent drivers from achieving full-time employment status.

Portfolio Pulse from

November 06, 2024 | 6:30 pm

TSLA

Tesla stock is experiencing significant gains following Donald Trump's election victory. The market perceives Trump's policies as favorable for Tesla, contributing to the stock's upward momentum.

Portfolio Pulse from

November 06, 2024 | 6:30 pm

DECA

SCLX

Semnur Pharmaceuticals, a subsidiary of Scilex Holding Company, announced the filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the SEC. This filing relates to the proposed business combination between Semnur and Denali.

Portfolio Pulse from

November 06, 2024 | 5:45 pm

TLT

The article discusses the current state of Treasury bonds and bond yields, highlighting their significance for investors as the Federal Reserve manages interest rates amidst the presidential election. The focus is on whether Treasury bonds, represented by the ETF TLT, will experience a breakout or breakdown.

Portfolio Pulse from

November 06, 2024 | 5:30 pm

ENPH

FSLR

Solar stocks, including First Solar and Enphase Energy, experienced a decline in early trading following the announcement of Donald Trump's presidential election victory.

Portfolio Pulse from

November 06, 2024 | 4:30 pm

GOOG

Google restricted political discussions on its internal message boards before the Election Day that resulted in Donald Trump's victory.

Portfolio Pulse from

November 06, 2024 | 4:30 pm

GMAB

Genmab reported a 29% revenue increase for the first nine months of 2024, reaching DKK 15,085 million. The European Commission granted conditional marketing authorization for TEPKINLY for treating follicular lymphoma. Genmab will also take sole responsibility for acasunlimab's development and potential commercialization.

Portfolio Pulse from

November 06, 2024 | 4:15 pm

BTGOF

Thursday is a significant day with major announcements expected from companies like BT, Sainsbury's, and Rolls-Royce, alongside interest rate decisions from the Federal Reserve and the Bank of England.

Portfolio Pulse from

November 06, 2024 | 4:00 pm